AR074528A1 - Dispositivos intravaginales con un soporte rigido, metodos para su fabricacion y sus usos - Google Patents

Dispositivos intravaginales con un soporte rigido, metodos para su fabricacion y sus usos

Info

Publication number
AR074528A1
AR074528A1 ARP090103117A ARP090103117A AR074528A1 AR 074528 A1 AR074528 A1 AR 074528A1 AR P090103117 A ARP090103117 A AR P090103117A AR P090103117 A ARP090103117 A AR P090103117A AR 074528 A1 AR074528 A1 AR 074528A1
Authority
AR
Argentina
Prior art keywords
rigid support
plastic
methods
matrix
combinations
Prior art date
Application number
ARP090103117A
Other languages
English (en)
Original Assignee
Duramed Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duramed Pharmaceuticals Inc filed Critical Duramed Pharmaceuticals Inc
Publication of AR074528A1 publication Critical patent/AR074528A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Steroid Compounds (AREA)

Abstract

Dispositivos intravaginales que tienen un soporte rígido; a métodos para la fabricación de los dispositivos intravaginales; y a sus usos. Los dispositivos comprenden: (a) un soporte rígido que tiene una Dureza Shore A de por lo menos aproximadamente 20 y una resistencia a la tracción de por lo menos aproximadamente 1 MPa; (b) una matriz; y (c) un ingrediente activo disperso en la matriz; donde el soporte y la matriz son adyacentes y donde el dispositivo anular. Reivindicación 5: El dispositivo de la reivindicación 1, donde el soporte comprende un metal, una aleación, un plástico, sus compuestos o sus combinaciones. Reivindicación 6: El dispositivo de la reivindicación 5, donde el plástico comprende un plástico termoplástico o un plástico termoestable. Reivindicación 14: El dispositivo de la reivindicación 1, donde el ingrediente activo es una hormona esteroide, un anticolinérgico, un anestésico, sus combinaciones o derivados. Reivindicación 15: El dispositivo de la reivindicación 1, donde el ingrediente activo es progesterona, estrógeno, oxibutinina, lidocaína, danazol, etonogestrel, etinilestradiol o sus combinaciones. Reivindicación 16: El dispositivo de la reivindicación 1, donde el dispositivo es un anillo vaginal.
ARP090103117A 2008-08-12 2009-08-12 Dispositivos intravaginales con un soporte rigido, metodos para su fabricacion y sus usos AR074528A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8831408P 2008-08-12 2008-08-12

Publications (1)

Publication Number Publication Date
AR074528A1 true AR074528A1 (es) 2011-01-26

Family

ID=41669143

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090103117A AR074528A1 (es) 2008-08-12 2009-08-12 Dispositivos intravaginales con un soporte rigido, metodos para su fabricacion y sus usos

Country Status (9)

Country Link
US (1) US20100040671A1 (es)
EP (1) EP2320871A4 (es)
JP (1) JP2011530379A (es)
AR (1) AR074528A1 (es)
AU (1) AU2009282496B2 (es)
CA (1) CA2733727A1 (es)
EA (1) EA021371B1 (es)
MX (1) MX338591B (es)
WO (1) WO2010019226A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013000002A (es) * 2001-07-27 2013-04-29 Teva Womens Health Inc Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
ES2921527T3 (es) 2009-06-03 2022-08-29 Forsight Vision5 Inc Administración de fármaco en segmento anterior
KR101914119B1 (ko) * 2010-03-16 2018-11-02 타이탄 파머슈티컬즈 인코퍼레이티드 약물 전달용 이종 이식가능 장치
CA2798034A1 (en) * 2010-03-28 2011-10-13 Evestra, Inc. Intravaginal drug delivery device
CN103154016A (zh) * 2010-05-05 2013-06-12 特卫华妇女健康有限公司 使用具有逐渐降低的释放速率的单剂型减轻对象症状的方法
US8939948B2 (en) 2010-06-01 2015-01-27 Forsight Vision5, Inc. Ocular insert apparatus and methods
TW201212939A (en) * 2010-06-22 2012-04-01 Anu Mahashabde Intravaginal devices comprising anticholinergic agents, and methods of making thereof
US8980304B2 (en) * 2010-08-20 2015-03-17 Teva Women's Health, Inc. Barrel-shaped vaginal ring
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
ZA201107786B (en) * 2010-10-26 2012-07-25 Maurice Roger Pope An inhibotor of pathogens
US9078813B2 (en) * 2010-11-12 2015-07-14 The University Of Utah Research Foundation Intravaginal devices for controlled delivery of lubricants
US8926493B2 (en) * 2011-04-11 2015-01-06 The Procter & Gamble Company Pessary device
US20120259160A1 (en) * 2011-04-11 2012-10-11 Nancy Karapasha Pessary device having improved comfort
PL2776055T3 (pl) * 2011-08-17 2017-06-30 Ironwood Pharmaceuticals, Inc. Sposoby leczenia zaburzeń żołądkowo-jelitowych
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
TW201332585A (zh) 2012-02-14 2013-08-16 Chemo Res S L 核鞘藥物遞送裝置
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
CN104884006B (zh) 2012-10-26 2017-12-15 弗赛特影像5股份有限公司 用于持续释放药物到眼睛的眼科系统
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JPWO2015041353A1 (ja) * 2013-09-20 2017-03-02 潤子 八木 子宮脱又は子宮下垂治療用リングペッサリー
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3017809A1 (en) 2014-11-07 2016-05-11 Ferring B.V. Drug-device unit containing quinagolide
EP3283004A4 (en) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
EP3432889B1 (en) 2016-03-23 2022-08-10 The University of North Carolina at Chapel Hill Geometrically complex intravaginal rings, systems and methods of making the same
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
AR125269A1 (es) * 2021-04-01 2023-06-28 Ceva Sante Animale Composiciones de progesterona de liberación controlada y sus utilizaciones
EP4395751A1 (en) 2021-08-31 2024-07-10 Ferring B.V. Diagnosis and treatment of ectopic endometriosis

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
US4034749A (en) * 1973-12-06 1977-07-12 Schering Aktiengesellschaft Intrauterine contraceptive device
US3993072A (en) * 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
DE2445971A1 (de) * 1974-09-24 1976-04-08 Schering Ag Arzneimittelwirkstofftraeger ii
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
US4286587A (en) * 1978-10-11 1981-09-01 Alza Corporation Vaginal drug delivery system made from polymer
US4215691A (en) * 1978-10-11 1980-08-05 Alza Corporation Vaginal contraceptive system made from block copolymer
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4308867A (en) * 1979-03-23 1982-01-05 Roseman Theodore J Two-member medicated device for rate-controlled administration of lipophilic pharmaceuticals
US4249531A (en) * 1979-07-05 1981-02-10 Alza Corporation Bioerodible system for delivering drug manufactured from poly(carboxylic acid)
US4402695A (en) * 1980-01-21 1983-09-06 Alza Corporation Device for delivering agent in vagina
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
NZ200564A (en) * 1982-05-10 1987-03-06 Ahi Operations Ltd Device for slowly releasing chemicals into body cavities of animals
US4629449A (en) * 1982-07-29 1986-12-16 Alza Corporation Vaginal dispenser for dispensing beneficial hormone
US4961931A (en) * 1982-07-29 1990-10-09 Alza Corporation Method for the management of hyperplasia
US4553972A (en) * 1983-05-20 1985-11-19 Syntex (U.S.A.) Inc. Disposable intravaginal contraceptive devices releasing 1-substituted imidazoles
NL8302103A (nl) * 1983-06-13 1985-01-02 Fundatech Sa Intravaginaal contraceptisch middel.
US4589880A (en) * 1983-07-14 1986-05-20 Southern Research Institute Disposable spermicide-releasing diaphragm
US4601893A (en) * 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
AU601170B2 (en) * 1985-06-19 1990-09-06 Fortune Capital Management B.V. Pessary
US4827946A (en) * 1988-01-06 1989-05-09 Steven Kaali Electrified vaginal ring
EP0687168B1 (en) * 1993-01-26 2000-05-24 Veos Limited Disposable vaginal device
ES2166894T3 (es) * 1995-07-04 2002-05-01 Akzo Nobel Nv Dispositivos anulares.
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
US6165166A (en) * 1997-04-25 2000-12-26 Schneider (Usa) Inc. Trilayer, extruded medical tubing and medical devices incorporating such tubing
US6982091B2 (en) * 2001-08-29 2006-01-03 Umd, Inc. Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
US20050276836A1 (en) * 1997-06-11 2005-12-15 Michelle Wilson Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents
US7744916B2 (en) * 1997-06-11 2010-06-29 Umd, Inc. Coated vaginal device for delivery of anti-migraine and anti-nausea drugs
US6572874B1 (en) * 1998-05-15 2003-06-03 Umd, Inc. Vaginal delivery of bisphosphonates
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
DE69929055T2 (de) * 1998-05-01 2006-07-20 Duramed Pharmaceuticals Inc., Cincinnati Verfahren zur spritzgussherstellung von vorrichtungen mit kontrollierter wirkstofffreisetzung und damit hergestellte vorrichtung
US6663639B1 (en) * 1999-06-22 2003-12-16 Ndo Surgical, Inc. Methods and devices for tissue reconfiguration
US7314716B2 (en) * 1999-11-19 2008-01-01 Mount Sinai School Of Medicine Gustducin γ subunit materials and methods
US6802807B2 (en) * 2001-01-23 2004-10-12 American Medical Systems, Inc. Surgical instrument and method
JP4273208B2 (ja) * 2001-03-30 2009-06-03 チッソ株式会社 婦人科疾患治療剤
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
US7004171B2 (en) * 2002-02-25 2006-02-28 Hi-Gienic Intra Vaginal Technologies Ltd. System for transvaginal drug delivery
EP1620060B1 (en) * 2003-04-29 2010-03-24 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
US20060275364A1 (en) * 2005-05-26 2006-12-07 Ahmed Salah U Flexible Solid Dosage Forms and Methods of Making and Using the Same

Also Published As

Publication number Publication date
EP2320871A4 (en) 2012-09-19
EA201170199A1 (ru) 2011-08-30
US20100040671A1 (en) 2010-02-18
CA2733727A1 (en) 2010-02-18
WO2010019226A1 (en) 2010-02-18
EP2320871A1 (en) 2011-05-18
AU2009282496A1 (en) 2010-02-18
AU2009282496B2 (en) 2015-08-06
EA021371B1 (ru) 2015-06-30
MX338591B (es) 2016-04-25
MX2011001605A (es) 2011-05-19
JP2011530379A (ja) 2011-12-22

Similar Documents

Publication Publication Date Title
AR074528A1 (es) Dispositivos intravaginales con un soporte rigido, metodos para su fabricacion y sus usos
CR8800A (es) Regimenes y equipos anticonceptivos de antagonistas del receptor de progesterona
CL2011003172A1 (es) Composicion farmaceutica que comprende a) un excepiente, b) al menos un precursor de esteroides sexuales, c) al menos un modulador selectivo del receptor de estrogenos o una antiestrogeno y no contiene una progestina y/o un estrogeno; kit farmaceutico; y uso para reducir o eliminar sofocos, sintomas vasomotores y sudores nocturnos.
CL2012001583A1 (es) Preparación oftálmica que comprende: a) povidona yodada, b) un agente refrescante y c) uno o más entre alcanfor, borneol, lubricante, emoliente, antiinflamatorio esteroidal y antinflamatorio no esteroidal; y su uso para el tratamiento y/o profilaxis de un trastorno ocular o una infección.
ECSP056082A (es) Terapia para enfermedad autoinmune en un paciente con una respuesta inadecuada a un inhibidor tnf-alfa
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
AR039794A1 (es) Formulaciones farmaceuticas de desmopresina
UY33343A (es) Formas de dosificación sólidas orales con dosis muy bajas para la hrt
RS53876B1 (en) PARENTERAL PHARMACEUTICAL FORM, WHICH RELEASES AROMATASE AND GESTAGEN BLOCKERS, FOR THE TREATMENT OF ENDOMETRIOSIS
AR053651A1 (es) Tratamiento combinado de anticuerpo antictla4 r inhibidor de aromatasa para el cancer de mama
CU20130019A7 (es) Hormona foliculoestimulante humana recombinante, composición farmacéutica que la comprende
DOP2005000248A (es) Agentes citotoxicos que comprendentaxanos nuevos.
CO6251360A2 (es) Bromhidrato de bupropion y aplicaciones terapeuticas
PE20181290A1 (es) Formulaciones y metodos para controlar el ciclo reproductivo y la ovulacion
AR040130A1 (es) Esteres de etonogestrel, su uso como anticopceptivo y para el tratamiento de desordenes ginecologicos
MY179398A (en) Plasticizing mixture for a hydraulic composition
AR038145A1 (es) Composicion de politartrato
CO2023000536A2 (es) Formas farmacéuticas de maleato de acalabrutinib
MX2020003667A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende un polimero de silicona.
CL2010001594A1 (es) Uso de nifurtimox para preparar un medicamento útil en el tratamiento de enfermedades causadas por trichomonadida.
ECSP109872A (es) Estratrienos 8-beta-sustituidos como estrógenos de acción selectiva
PE20130639A1 (es) Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva
CL2021001762A1 (es) Uso del estetrol como tratamiento para la endometriosis
CL2015001368A1 (es) Metodo para anticoncepcion controlada que comprende administrar una preparacion farmaceutica que comprende levonorgestrel y un inhibidor de la cox; uso de la composicion farmaceutica en la anticoncepcion "a la carta".
AR095694A4 (es) Profiláctico femenino

Legal Events

Date Code Title Description
FB Suspension of granting procedure